Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas
Clinical trial NCT02822066 · UNKNOWN
Trial details
- NCT number
- NCT02822066
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.